Trials / Completed
CompletedNCT00534794
Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis
A Single-Center, Masked, Randomized Study Comparing Two Marketed Ocular Anti-Allergy Medications in the Cat Room Model
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effects of two marked ocular anti-allergy medications in cat sensitive subjects with allergic conjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Elestat | Elestat BID for 2 days |
| DRUG | Pataday | Pataday QD for 2 days |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-01-01
- First posted
- 2007-09-26
- Last updated
- 2015-05-13
- Results posted
- 2009-05-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00534794. Inclusion in this directory is not an endorsement.